COST PLUS DRUG COMPANY Trademark

Trademark Overview

On Friday, March 11, 2022, a trademark application was filed for COST PLUS DRUG COMPANY with the United States Patent and Trademark Office. The USPTO has given the COST PLUS DRUG COMPANY trademark a serial number of 97307454. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, May 29, 2024. This trademark is owned by Mark Cuban Cost Plus Drug Company, PBC. The COST PLUS DRUG COMPANY trademark is filed in the Pharmaceutical Products category with the following description:

House mark for a full line of pharmaceutical preparations
cost plus drug company

General Information

Serial Number97307454
Word MarkCOST PLUS DRUG COMPANY
Filing DateFriday, March 11, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, May 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesHouse mark for a full line of pharmaceutical preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 16, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMark Cuban Cost Plus Drug Company, PBC
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLittleton, CO 80123

Trademark Events

Event DateEvent Description
Tuesday, March 15, 2022NEW APPLICATION ENTERED
Wednesday, March 16, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 22, 2022ASSIGNED TO EXAMINER
Thursday, December 29, 2022NON-FINAL ACTION WRITTEN
Thursday, December 29, 2022NON-FINAL ACTION E-MAILED
Thursday, December 29, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 10, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 10, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 10, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 28, 2023SUSPENSION LETTER WRITTEN
Friday, April 28, 2023LETTER OF SUSPENSION E-MAILED
Friday, April 28, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, November 15, 2023FINAL REFUSAL WRITTEN
Wednesday, November 15, 2023FINAL REFUSAL E-MAILED
Wednesday, November 15, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, February 12, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, May 29, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, May 29, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, February 12, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Related Keywords

company drug plus cost pharmaceutical preparations line full mark house